Author:
Yang H.,Craig D.,Epstein D.,Bojke L.,Light K.,Bruce I. N.,Sculpher M.,Woolacott N.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy
Reference34 articles.
1. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE; 2008.
2. Antoni C, Krueger, GG, de Vlam, K, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. 2005;64(8):1150–7.
3. Yang H, Epstein D, Bojke L, et al. Evidence Review Group’s report: golimumab for the treatment of psoriatic arthritis. London: NIHR HTA; 2010.
4. National Institute for Health and Clinical Excellence. Guide to the single technology appraisal (STA) process. London: NICE; 2006.
5. Sculpher M. Single technology appraisal at the UK National Institute for Health and Clinical Excellence: a source of evidence and analysis for decision making internationally. PharmacoEconomics. 2010;28(5):347–9.